BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses
Coronavirus chronicle
30 March, 2021, 04:55 pm
Last modified: 30 March, 2021, 05:00 pm
Pfizer previously said the two partners would likely produce between 2.3 billion and 2.4 billion doses this year
FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
BioNTech said on Tuesday that it and partner Pfizer expect to increase manufacturing capacity of their Covid-19 vaccine to 2.5 billion doses by the end of 2021, after bringing a new German facility on stream.
Pfizer previously said the two partners would likely produce between 2.3 billion and 2.4 billion doses this year.
BioNTech also cited an expansion of the pair's network of third-party manufacturers and suppliers as a driver behind the larger volumes.
"Additional measures and discussions with potential partners to further expand the manufacturing capacity and network are ongoing," it added.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.